Help! Please Register
IQ Option www.iqoption.com.pk/ پاکستان میں


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: Education & Tools >
Merck & Co., Inc.

idemex.com
Course and Test - take it your way
Start CME
Help!
000


CME
Course Title:
Advancing the Art of Antifungal Therapy:
New therapeutic options and treatment strategies



Target Audience:

This activity will be of relevance to hematologists, oncologists, critical care specialists and infectious disease specialists. In addition, this program will provide useful information and guidance to all medical professionals who should be aware of the latest developments in fungal infections.

Up   

Activity description:

Welcome to this exciting CME-accredited activity "Advancing the Art of Antifungal Therapy: New therapeutic options and treatment strategies".

There has recently been an increase in both the choice of treatment options and available clinical information for the treatment of systemic fungal infections. This wide range of information can prove to be overwhelming for the physician who must select the best treatment strategy for their patients. This webcast will review available clinical data in support of various treatment options and approaches in order to provide clear guidance to physicians.
Up   

Learning objectives:

On completion of this activity, the participant should be able to:
  • Review the epidemiology of fungal infections in immunosuppressed patients
  • Compare the different treatment approaches to fungal infections
  • Discuss the clinical indications for each treatment approach
  • Analyze the latest clinical data on therapeutic options
  • Evaluate the optimal treatment strategy for their individual patients.
Up   

Faculty and disclosure statement:

Thomas F. Patterson, MD, FACP
Professor of Medicine
The University of Texas Health Science Center at San Antonio
San Antonio, TX

CME Consultants, Inc. holds the standard that its continuing medical education activities be free of commercial bias.

Now, in accordance with the disclosure policy of CME Consultants, Inc., as well as standards set forth by the ACCME, the ANCC and the ACPE, faculty have been asked to disclose any relationship they have to companies producing pharmaceuticals, medical equipment, prostheses, etc. that might be germane to the content of their lectures and any relationship they have with the commercial supporter(s) of the activity. Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide registrants with information that might be of potential importance to their evaluation of a given talk. The faculty is also aware it is their responsibility to inform the audience if discussion of any non-FDA approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.

Faculty have reported receiving something of value* from a company whose product may be germane to the content of their presentations.

Name
Relationship
Company
Thomas F. Patterson
Consultant
BMS, Fujisawa, Merck, Microbia, Pfizer, Schering-Plough, Uriach Versicor

Grant support

Fujisawa, Merck, Pfizer, Schering-Plough
Speaker bureau

Merck, Pfizer


* "Something of value" refers to an equity position, vested interest, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for education services elsewhere, or to any other relationship to a company that provides suffi cient reason for disclosure, in keeping with the spirit of the stated policy.

Accreditation:

CME Consultants, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Consultants, Inc. designates this educational activity for a maximum of 1 (one) category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Date of original release: August 2004

Valid for CME credit through August 31, 2005



Up   




This CME is supported by an unrestricted educational grant from
    Merck and Co., Inc.
Program Organizer:

Privacy Policy
Contact: mycosesstudygroup.org
Site Contents Copyright © 2007 mycosesstudygroup.org

 





  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif